Table 2.

Previous anti-TNFα exposure and reason for discontinuation

Prior anti-TNFα exposure, n [%]
No	387 [22.9]
Yes	1306 [77.1]
Intolerance of former anti-TNFα therapy	72/1306 [5.5]
Loss of response to former anti-TNFα therapy	727/1306 [55.7]
Acute AEs	306/1306 [23.4]
Delayed AEs	100/1306 [7.7]
Others	136/1306 [10.4]

AE, adverse event; TNF, tumour necrosis factor.